The Oncology Institute, Inc. TOI Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s common stock?
- The Oncology Institute, Inc. (TOI) reported common stock of 500M in Q1 2026.
- How has The Oncology Institute, Inc.'s common stock changed year-over-year?
- The Oncology Institute, Inc.'s common stock decreased by 0.0% year-over-year, from 500M to 500M.
- What is the long-term trend for The Oncology Institute, Inc.'s common stock?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s common stock has grown at a 864.2% compound annual growth rate (CAGR), from 6K to 500M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).